Skip to main content

Table 1 Clinical studies investigating the association between acute kidney injury and delirium

From: Acute kidney injury-associated delirium: a review of clinical and pathophysiological mechanisms

Author(s)

Year

Methodology

AKI criteria

Strengths/Limitations

Conclusion

Wan et al.

2019

Case–control study

142 cases, 142 controls

KDIGO

Strengths: Matched case–control design using prevalent cases over a 1-year period. 97% specific for method to detect hyperactive delirium

Limitations: Single-center study. Retrospective design limited to data recorded in electronic health records

AKI stage 3 is associated with hyperactive delirium (OR 5.40, 95% CI 2.33–12.51). AKI stages 1 and 2 were not independently associated with hyperactive delirium

Pisani et al.

2007

Prospective cohort (n = 304)

Serum creatinine level > 2 mg/dL

Strengths: At the time, the largest collection of data on delirium among older ICU patients. First to examine admission risk factors

Limitations: Missing data on risk factors, specifically liver function test and arterial pH. Lack of generalization to younger population. Acute vs. chronic serum creatinine level > 2 was not distinguished as being associated with delirium

Serum creatinine level of > 2 mg/dL is an admission risk factor for delirium (OR 2.1, 95% CI 1.1–4.0)

Siew et al.

2017

Prospective cohort (n = 466)

KDIGO

Strength: Large sample size and prospective design. Findings persisted when using an alternative definition for AKI

Limitations: Single-center population. Excluded patients with overt neurologic disorders. Did not have preadmission kidney function on all patients

AKI stage 2 (OR 1.55; 95% CI, 1.07–2.26) and stage 3 (OR 2.56; 95% CI, 1.57–4.16) are associated with delirium. AKI stage 1 was not significantly associated with delirium (OR 1.13, 95% CI 0.91–1.41)

Zipser et al.

2019

Prospective cohort (n = 1487)

Medical diagnoses data retrieved from the electronic medical chart (Klinikinformationssystem, KISIM, CisTec AG, Zurich) described as diagnostic clusters according to the 10th revision of the International Classification of Diseases (ICD-10)

Strength: Systemically assessed predisposing and precipitating factors for delirium. Ample sample size

Limitations: Selection of delirium-relevant ICD-10 codes chosen. Not all codes could be included and information may be skewed or lost in this process

AKI is associated with delirium

(OR 10.01, CI 1.13–88.73, p = 0.039). Chronic kidney disease is not associated with delirium (OR 1.04, CI 0.61–1.78, p = 0.891)

Jäckel et al.

2021

Retrospective cohort (n = 919)

KDIGO

Strength: Adjusted for confounders of delirium thereby reducing bias

Limitations: Used NuDesc to define delirium, hence definition not congruent to DSM-5 definition. Retrospective study. Baseline kidney functions not determined in all cases

Delirium is independently predicted by AKI stage 2/3 (OR 1.69, CI 1.04–2.73, p = 0.033)

  1. AKI, Acute kidney injury; OR, odds ratio; CI, confidence interval; KDIGO, Kidney Disease: Improving Global Outcomes; and HR, hazards ratio